Ayson, Franklen C.
HRN: 22-31-91 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/23/2023
08/30/2023
IV INFUSION
4.5g
Q6hrs ( ) ANST
S/P Exlap
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes